Why the study?
Does rivaroxaban improve acute portal vein thrombosis in a patient with compensated cirrhosis?
Population
A 50-year-old white man with extreme obesity, heart failure, hypertension, diabetes mellitus type 2, and…
Design
Case_report
Follow-up
6 months
Authors
Loading...
May support rivaroxaban for acute PVT in compensated cirrhosis; hypothesis-generating, needs prospective validation.
Does rivaroxaban improve acute portal vein thrombosis in a patient with compensated cirrhosis?
Rivaroxaban successfully treated acute portal and mesenteric vein thrombosis in a patient with compensated cirrhosis without causing bleeding complications.
Martínez et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: